Could an old HIV drug help fight cancer?

This study tests whether adding lamivudine, an HIV drug, to standard immunotherapy can help shrink or control advanced solid tumors that have stopped responding to treatment. About 12 to 24 adults with various solid cancers will receive lamivudine alongside their current immunotherapy. The goal is to see if this combination is safe and can slow tumor growth.